{
    "organizations": [],
    "uuid": "37d84084962b1593d1202512c459692dc14067cc",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-north-china-pharmaceutical-receive/brief-north-china-pharmaceutical-receives-gmp-certificate-idUSL4N1Q226E",
    "ord_in_thread": 0,
    "title": "BRIEF-North China Pharmaceutical receives GMP certificate",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 12 (Reuters) - North China Pharmaceutical Co Ltd :\n* Says it received goods manufacture practice (GMP) certificate from Hebei Food and Drug Administration\n* Certificate issued tablets and hard capsules production line manufactured by the company and the valid period is until Jan. 17, 2023\nSource text in Chinese: goo.gl/kufQSY\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-12T14:12:00.000+02:00",
    "crawled": "2018-02-13T15:44:52.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "north",
        "china",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "received",
        "good",
        "manufacture",
        "practice",
        "gmp",
        "certificate",
        "hebei",
        "food",
        "drug",
        "administration",
        "certificate",
        "issued",
        "tablet",
        "hard",
        "capsule",
        "production",
        "line",
        "manufactured",
        "company",
        "valid",
        "period",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}